| Year |
Citation |
Score |
| 2008 |
Zhang CS, Bertaso F, Eulenburg V, Lerner-Natoli M, Herin GA, Bauer L, Bockaert J, Fagni L, Betz H, Scheschonka A. Knock-in mice lacking the PDZ-ligand motif of mGluR7a show impaired PKC-dependent autoinhibition of glutamate release, spatial working memory deficits, and increased susceptibility to pentylenetetrazol. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8604-14. PMID 18716219 DOI: 10.1523/Jneurosci.0628-08.2008 |
0.658 |
|
| 2008 |
Caldwell JH, Herin GA, Nagel G, Bamberg E, Scheschonka A, Betz H. Increases in intracellular calcium triggered by channelrhodopsin-2 potentiate the response of metabotropic glutamate receptor mGluR7. The Journal of Biological Chemistry. 283: 24300-7. PMID 18599484 DOI: 10.1074/Jbc.M802593200 |
0.512 |
|
| 2004 |
Herin GA, Aizenman E. Amino terminal domain regulation of NMDA receptor function. European Journal of Pharmacology. 500: 101-11. PMID 15464024 DOI: 10.1016/J.Ejphar.2004.07.015 |
0.679 |
|
| 2004 |
Lu Y, Li Y, Herin GA, Aizenman E, Epstein PM, Rosenberg PA. Elevation of intracellular cAMP evokes activity-dependent release of adenosine in cultured rat forebrain neurons. The European Journal of Neuroscience. 19: 2669-81. PMID 15147301 DOI: 10.1111/J.0953-816X.2004.03396.X |
0.685 |
|
| 2002 |
Legos JJ, McLaughlin B, Skaper SD, Strijbos PJ, Parsons AA, Aizenman E, Herin GA, Barone FC, Erhardt JA. The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. European Journal of Pharmacology. 447: 37-42. PMID 12106800 DOI: 10.1016/S0014-2999(02)01890-3 |
0.666 |
|
| 2001 |
Herin GA, Du S, Aizenman E. The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site. Journal of Neurochemistry. 78: 1307-14. PMID 11579139 DOI: 10.1046/J.1471-4159.2001.00517.X |
0.747 |
|
| 2000 |
Aizenman E, Sinor JD, Brimecombe JC, Herin GA. Alterations of N-methyl-D-aspartate receptor properties after chemical ischemia. The Journal of Pharmacology and Experimental Therapeutics. 295: 572-7. PMID 11046090 |
0.465 |
|
| Show low-probability matches. |